Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qing-Gan Huo-Xue decoction (QGHXD) is a Traditional Chinese Medicine (TCM) herbal formula developed by Longhua Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine, for the treatment of alcoholic liver disease (ALD). The decoction is designed according to TCM principles to clear liver heat and promote blood circulation to resolve stasis, targeting the inflammatory and fibrotic processes associated with chronic alcohol consumption. In clinical trials, QGHXD has been evaluated for its ability to improve liver function enzymes, reduce serum markers of hepatic fibrosis, and decrease liver stiffness as assessed by transient elastography. It is typically administered as an oral decoction and has been studied in comparison to standard hepatoprotective agents such as polyene phosphatidylcholine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qing-gan huo-xue decoction.